Vanguard Group
CRTX

Vanguard Group’s CORNERSTONE THERAPEUTICS INC CRTX Stock Holding History

Vanguard Group’s Portfolio CRTX Stock Details CRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-182,654
Closed -$1.73M – 3992
2013
Q4 		$1.73M Buy
182,654
+4,735
+3% +$44.8K ﹤0.01% 3245
2013
Q3 		$1.67M Buy
177,919
+9,187
+5% +$82.8K ﹤0.01% 3204
2013
Q2 		$1.35M Buy
+168,732
New +$1.42M ﹤0.01% 3209

Other funds holding CRTX

AA
Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return

Vanguard Group's CRTX Position: Q1 2014 in Review

Vanguard Group sold out of CORNERSTONE THERAPEUTICS INC (CRTX) in Q1 2014, closing a stake of 182,654 shares — an estimated $1.73M sold.

Vanguard Group first reported a position in CRTX in Q2 2013 and held it in 3 quarters. The position peaked at $1.73M in Q4 2013. 1 fund tracked by Wall St. Rank holds CRTX as of Q1 2014.

  • Vanguard Group reported no remaining CORNERSTONE THERAPEUTICS INC position as of Q1 2014 after selling out during the quarter.
  • Vanguard Group sold 182,654 CORNERSTONE THERAPEUTICS INC shares in Q1 2014, an estimated $1.73M.
  • Vanguard Group first reported a position in CORNERSTONE THERAPEUTICS INC in Q2 2013 and held it in 3 quarters.
  • Vanguard Group's CORNERSTONE THERAPEUTICS INC position peaked at $1.73M in Q4 2013.
  • 1 fund tracked by Wall St. Rank held CORNERSTONE THERAPEUTICS INC as of Q1 2014.

Based on Vanguard Group's 13F filing for Q1 2014, filed 13 May 2014.